Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A

International Journal of Pharmaceutics

Volumn 367, Issue 1-2, 2009, Pages 115-126

  Libster, Dima ^a   Ishai, Paul Ben ^a   Aserin, Abraham ^a   Shoham, Gil ^a   Garti, Nissim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

ATR FTIR; Cyclosporin A; Glycerol monooleate; Liquid crystals; Phosphatidylcholine; Reverse hexagonal phase

Indexed keywords

AMIDE; CARBONYL DERIVATIVE; CYCLOSPORIN A; HYDROGEN; HYDROXYL GROUP; PHOSPHATE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SURFACTANT; TRIOCTANOIN; WATER;

ARTICLE; CHEMICAL STRUCTURE; CONFORMATION; CONFORMATIONAL TRANSITION; DRUG SOLUBILITY; HYDRATION; HYDROGEN BOND; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; PRIORITY JOURNAL; STRENGTH; WATER SUPPLY;

CYCLOSPORINE; DRUG CARRIERS; GLYCERIDES; LIPOSOMES; LIQUID CRYSTALS; MOLECULAR STRUCTURE; OCTANOIC ACIDS; PHASE TRANSITION; PHOSPHATIDYLCHOLINES; PROTEIN CONFORMATION; SCATTERING, SMALL ANGLE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES; WATER;

EID: 58249100038     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.09.048     Document Type: Article

References (60)

1. Aliabadi H.M., Elhasi S., Mahmud A., Gulamhusein R., Mahdipoor P., and Lavasanifar A. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading. Int. J. Pharm. 329 (2007) 158-165
2. Altschuh D., Braun W., Kallen J., Mikol V., Spitzfaden C., Thierry J.-C., Vix O., Walkinshaw M.D., and Wüthrich K. Conformational polymorphism of cyclosporin A. Structure 2 (1994) 963-972
3. Amar-Yuli I., and Garti N. Transitions induced by solubilized fat into reverse hexagonal mesophases. Colloid Surf. B 43 (2005) 72-82
4. Amar-Yuli I., Wachtel E., Ben Shoshan E., Danino D., Aserin A., and Garti N. Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer. Langmuir 23 (2007) 3637-3645
5. Amar-Yuli I., Wachtel E., Shalev D.E., Aserin A., and Garti N. Low viscosity reversed hexagonal mesophases induced by hydrophilic additives. J. Phys. Chem. B 112 (2008) 3971-3982
6. II) mesophase. J. Phys. Chem. B 111 (2007) 13544-13553
7. Barth A. Infrared spectroscopy of proteins. Biochim. Biophys. Acta 1767 (2007) 1073-1101
8. Bender F., Chilcott T.C., Coster H.G.L., Hibbert D.B., and Gooding J.J. Characterisation of mesoporous polymer films deposited using lyotropic liquid crystal templating. Electrochim. Acta 52 (2007) 2640-2648
9. Bodack L.A., Freedman T.B., Chowdhry B.Z., and Nafie L.A. Solution conformations of cyclosporins and magnesium-cyclosporin complexes determined by vibrational circular dichroism. Biopolymers 73 (2004) 163-177
10. Boyd B.J., Khoo S.-M., Whittaker D.V., Davey G., and Porter C.J.H. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. Int. J. Pharm. 340 (2007) 52-60
11. Boyd B.J., Whittaker D.V., Khoo S.-M., and Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int. J. Pharm. 309 (2006) 218-226
12. Clogston J., and Caffrey M. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. J. Control. Release 107 (2005) 97-111
13. Dan-Dan Z., Mao W.X., Wen-Jia Z., Jin Z., and Hu L.L. Preparation of ordered mesoporous nickel oxide film electrodes via lyotropic liquid crystal templated electrodeposition route. Electrochim. Acta 53 (2008) 2699-2705
14. Dong A., Huang P., and Caughey W.S. Protein secondary structures in water from second-derivative Amide I infrared spectra. Biochemistry 29 (1990) 3303-3308
15. Drummond C.J., and Fong C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr. Opin. Colloid Interf. Sci. 4 (1999) 449-456
16. Efrat R., Aserin A., and Garti N. On structural transitions in a discontinuous micellar cubic phase loaded with sodium diclofenac. J. Colloid Interf. Sci. 321 (2008) 166-176
17. Fahr A., Hoogevest P.V., May S., Bergstrand N., and Leigh M.L.S. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. Eur. J. Pharm. Sci. 26 (2005) 251-265
18. Fahr A., and Seelig J. Liposomal formulations of Cyclosporin A: a biophysical approach to pharmacokinetics and pharmacodynamics. Crit. Rev. Ther. Drug Carrier Syst. 18 (2001) 141-172
19. Farkas E., Kiss D., and Zelkó R. Study on the release of chlorhexidine base and salts from different liquid crystalline structures. Int. J. Pharm. 340 (2007) 71-75
20. Fournier I., Barwicz J., Auger M., and Tancréde P. The chain conformational order of ergosterol- or cholesterol-containing DPPC bilayers as modulated by Amphotericin B: a FTIR study. Chem. Phys. Lipids 151 (2008) 41-50
21. Gabizon A., Shmeeda H., and Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin - review of animal and human studies. Clin. Pharmacokinet. 42 (2003) 419-436
22. Getie M., Wohlrab J., and Neubert R.H.H. Dermal delivery of desmopressin acetate using colloidal carrier systems. J. Pharm. Pharmacol. 57 (2005) 423-427
23. Guillén M., and Cabo D.N. Infrared spectroscopy in the study of edible oils. J. Sci. Food Agric. 75 (1997) 1-11
24. Gursoy R.N., and Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved orFal delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004) 173-182
25. Holmgren A., Lindblom G., and Johansson L.B.-A. Intramolecular hydrogen bonding in a monoglyceride lipid studied by fourier transform infrared spectroscopy. J. Phys. Chem. 92 (1988) 5639-5642
26. Hübner W., and Blume A. Interactions at the lipid-water interface. Chem. Phys. Lipids 96 (1998) 99-123
27. 13C{double bond, long}O labeled phosphatidylcholine multilayers from polarized attenuated total reflection FT-IR spectroscopy. Biophys. J. 59 (1991) 1261-1272
28. Hussain S., Grandy D.B., Reading M., Craig D.Q.M., and Craig. A study of phase separation in peptide-loaded HPMC films using Tzero-modulated temperature DSC, atomic force microscopy, and scanning electron microscopy. J. Pharm. Sci. 93 (2004) 1672-1681
29. Italia J.L., Bhardwaj V., and Kumar M.N.V.R. Disease, destination, dose and delivery aspects of ciclosporin: the state of the art. Drug Discov. Today 11 (2006) 846-854
30. Lake J.A. An iterative method of slit-correcting small angle X-ray data. Acta Crystallogr. 23 (1967) 191-194
31. Lambros M.P., and Rahman Y.E. Effects of Cyclosporin A on model lipid membranes. Chem. Phys. Lipids 131 (2004) 63-69
32. Larsson K. Cubic lipid-water phases: structures and biomembrane aspects. J. Phys. Chem. 93 (1989) 7304-7314
33. Legrue S.J., Friedman A.W., and Kahan B.D. Binding of cyclosporine by human lymphocytes and phospholipid-vesicles. J. Immunol. 131 (1983) 712-718
34. II liquid crystal-based delivery system for cyclosporin A: physical characterization. J. Colloid Interf. Sci. 308 (2007) 514-524
35. Libster D., Ben Ishai P., Aserin A., Shoham G., and Garti N. From the microscopic to the mesoscopic properties of lyotropic reverse hexagonal liquid crystals. Langmuir 24 (2008) 2118-2127
36. Liu H., Wang Y., and Li S. Advanced delivery of Cyclosporin A: present state and perspective. Expert Opin. Drug Deliv. 4 (2007) 349-358
37. Lopes L.B., Lopes J.L.C., Oliveira D.C.R., Thomazini J.A., Garcia M.T.J., Fantini M.C.A., Collett J.H., and Bently M.V.L.B. Liquid crystalline phases of monoolein and water for topical delivery of Cyclosporin A: characterization and study of in vitro and in vivo delivery. Eur. J. Pharm. Biopharm. 63 (2006) 146-155
38. Lopes L.B., Ferreira D.A., De Paula D., Garcia M.T.J., Thomazini J.A., Fantini M.C.A., and Bently V.L.B. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm. Res. 23 (2006) 1332-1342
39. Lopes L.B., Speretta F.F.F., and Bentley M.V.L.B. Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems. Eur. J. Pharm. Sci. 32 (2007) 209-215
40. 2 rocking modes as quantitative infrared probes of one-, two-, and three-bond conformational disorder in dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylcholine/cholesterol mixture. Biochemistry 30 (1991) 8558-8563
41. Misiunas A., Niaura G., Talaikytė Z., Eicher-Lorka O., and Razumas V. Infrared and Raman bands of phytantriol as markers of hydrogen bonding and interchain interaction. Spectrochim. Acta Part A 62 (2005) 945-957
42. Nilsson A., Holmgren A., and Lindblom G. Fourier-transform infrared spectroscopy study of dioleoylphosphatidylcholine and monooleoylglycerol in lamellar and cubic liquid crystals. Biochemistry 30 (1991) 2126-2133
43. Nilsson A., Holmgren A., and Lindblom G. An FTIR study of the hydration and molecular ordering at phase transitions in the monooleoylglycerol/water system. Chem. Phys. Lipids 71 (1994) 119-131
44. Qiu H., and Caffrey M. The phase diagram of the monoolein/water system: metastability and equilibrium aspects. Biomaterials 21 (2000) 223-234
45. Razumas V., Larsson K., Miezes Y., and Nylander T. A cubic monoolein-cytochrome C-water phase: X-ray diffraction, FT-IR, differential scanning calorimetric and electrochemical studies. J. Phys. Chem. 100 (1996) 11766-11774
46. Sagalowicz L., Mezzenga R., and Leser M.E. Investigating reversed liquid crystalline mesophases. Curr. Opin. Colloid Interf. Sci. 11 (2006) 224-229
47. Sagalowicz L., Leser M.E., Watzke H.J., and Michel M. Monoglyceride self-assembly structures as delivery vehicles. Trends Food Sci. Technol. 17 (2006) 204-214
48. Shah M.H., and Paradkar A. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme. Int. J. Pharm. 294 (2005) 161-171
49. Shaw R.A., Mantsch H.H., and Chowdhry B.Z. Conformational changes in the cyclic undecapeptide cyclosporin induced by interaction with metal ions. An FTIR study. Int. J. Biol. Macromol. 16 (1994) 143-148
50. Song K.-H., Fasano A., and Eddington N.D. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. Int. J. Pharm. 351 (2008) 8-14
51. Stevenson C.L., Tan M.M., and Lechuga-Ballesteros D. Secondary structure of cyclosporine in a spray-dried liquid crystal by FTIR. J. Pharm. Sci. 92 (2003) 1832-1843
52. Swarnakar N.K., Jain V., Dubey V., Mishra D., and Jain N.K. Enhanced oromucosal delivery of progesterone via hexosomes. Pharm. Res. 24 (2007) 2223-2230
53. Talaikytė Z., Barauskas J., Niaura G., Švedaitė I., Butkus E., Razumas V., and Nylander T. Interactions of cyclic AMP and its dibutyrylanalogue with a lipid layer in the aqueous mixtures of monoolein preparation and dioleoyl phosphatidylcholine as probed by X-ray diffraction and Raman spectroscopy. J. Biol. Phys. 30 (2004) 83-96
54. Vass E., Hollosi M., Besson F., and Buchet R. Vibrational spectroscopic detection of beta- and gamma-turns in synthetic and natural peptides and proteins. Chem. Rev. 103 (2003) 1917-1954
55. Weber C., Wider G., von Freyberg B., Traber R., Braun W., Widmer H., and Wuthrich K. The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution. Biochemistry 30 (1991) 6563-6574
56. Woo J.S., Piao M.G., Li D.X., Ryu D.-S., Choi J.Y., Kima J.-A., Kim J.H., Jin S.G., Kim D.-D., Lyoo W.S., Yong C.S., and Choi H.-G. Development of cyclosporin A-loaded hyaluronic microsphere with enhanced oral bioavailability. Int. J. Pharm. 345 (2007) 134-141
57. Wuthrich K., von Freyberg B., Weber C., Wider G., Traver R., Widmer H., and Braun W. Receptor-induced conformation change of the immunosuppressant cyclosporin A. Science 254 (1991) 953-954
58. Zhang J., and Yan Y.-B. Probing conformational changes of proteins by quantitative second-derivative infrared spectroscopy. Anal. Biochem. 340 (2005) 89-98
59. Zidan A.S., Sammour O.A., Hammad M.A., Megrab N.A., Habib M.J., and Khan M.A. Quality by design: understanding the formulation variables of a Cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. Int. J. Pharm. 332 (2007) 55-63
60. Zijlstra G.S., Rijkeboer M., Jan van Drooge D., Sutter M., Jiskoot W., van de Weert M., Hinrichs W.L., and Frijlink H.W. Characterization of a cyclosporine solid dispersion for inhalation. AAPS J. 9 (2007) E190-E199